Work

A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone (DP) with or without Lenalidomide (LEN) in Patients with Castrate-Resistant Prostate Cancer (CRPC): The Mainsail Trial

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)34329-5

Authors: D.P. Petrylak, K. Fizazi, C.N. Sternberg, N. Budnik, R. De Wit, P.J. Wiechno, J. Bellmunt, D. Barton, A. Fandi, U. Jungnelius, S. Li, N. Vogelzang

Institutions: Columbia University Irving Medical Center, Institut Gustave Roussy, Azienda Ospedaliera San Camillo-Forlanini, Carlo Forlanini Hospital, Russian Railways, Erasmus MC, Daniel den Hoed Kliniek, The Maria Sklodowska-Curie National Research Institute of Oncology, Hospital Del Mar, Celgene (United States), Comprehensive Cancer Centers of Nevada

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999598241

FWCI: 9.012

Cites:

Cited by: 39

Related to: 10